论文信息 - Therapeutic effects of genetically engineered toxin (DAB486IL-2) in patient with chronic lymphocytic leukaemia - 字舞流文

Therapeutic effects of genetically engineered toxin (DAB486IL-2) in patient with chronic lymphocytic leukaemia

J. Reuben | A. Deisseroth | D. Parkinson | T. Woodworth | K. Parker | C. Lemaistre | C. Meneghetti | M. Rosenblum | J. Shaw

[1] R. S. Watson,et al. Cellular processing of the interleukin-2 fusion toxin DAB486-IL-2 and efficient delivery of diphtheria fragment A to the cytosol of target cells requires Arg194. , 1990, The Journal of biological chemistry.

[2] Kendall A. Smith,et al. Interleukin 2 receptor‐targeted cytotoxicity. Receptor binding requirements for entry of a diphtheria toxin‐related interleukin 2 fusion protein into cells , 1990, European journal of immunology.

[3] T. Strom,et al. Cytotoxicity of interleukin 2-toxin toward lymphocytes from patients with adult T-cell leukemia. , 1989, Cancer research.

[4] G. Marti,et al. Expression of interleukin-2 receptor beta subunit in hematopoietic malignancies , 1989 .

[5] T. Waldmann,et al. Expression of functional IL 2 receptors by lipopolysaccharide and interferon-gamma stimulated human monocytes. , 1987, Journal of immunology.

[6] K. Kato,et al. Interleukin 2 high-affinity receptor expression requires two distinct binding proteins , 1987, The Journal of experimental medicine.

[7] T. Waldmann. The structure, function, and expression of interleukin-2 receptors on normal and malignant lymphocytes. , 1986, Science.

[8] E. Mekada,et al. One molecule of diphtheria toxin fragment a introduced into a cell can kill the cell , 1978, Cell.